Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MacuHealth is a science-based nutraceutical company dedicated to preserving vision and enhancing visual performance through specialized nutritional supplementation. The company focuses on the three macular carotenoids—Lutein, Zeaxanthin, and Meso-zeaxanthin—which are critical for protecting the eye from blue light and oxidative damage. Their products are formulated based on rigorous clinical trials, such as the CREST study, and are widely recommended by eye care professionals for patients with or at risk of age-related macular degeneration. MacuHealth's portfolio has expanded to include solutions for vitreous floaters and cognitive health, emphasizing the role of carotenoids in overall neurological and ocular wellness. The company maintains a strong commitment to scientific validation and quality, ensuring their supplements meet pharmaceutical-grade standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Eyecarotenoids.com.